AMOÉBA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.51 EUR | +6.25% |
|
+10.87% | +32.81% |
| Mar. 28 | Amoéba S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Feb. 05 | Amoéba: share price rises after strategic shift | CF |
Valuation
| Fiscal Period: December | 2018 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Capitalization 1 | 13.32 | 19.17 | 25.31 | 25.31 | - |
| Enterprise Value (EV) 1 | 13.32 | 16 | 19.06 | 25.31 | 25.31 |
| P/E ratio | - | -3.4 x | -2.68 x | - | - |
| Yield | - | - | - | - | - |
| Capitalization / Revenue | 109 x | - | - | - | 28.1 x |
| EV / Revenue | 109 x | - | - | - | 28.1 x |
| EV / EBITDA | - | -3.01 x | -4.55 x | - | - |
| EV / FCF | -2.31 x | - | -4.93 x | -3.84 x | -3.01 x |
| FCF Yield | -43.2% | - | -20.3% | -26.1% | -33.2% |
| Price to Book | - | - | - | - | - |
| Nbr of stocks (in thousands) | 6,001 | 22,548 | 49,634 | 49,634 | - |
| Reference price 2 | 2.220 | 0.8500 | 0.5100 | 0.5100 | 0.5100 |
| Announcement Date | 3/22/19 | 3/30/23 | 3/28/24 | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net sales 1 | 0.122 | - | - | - | - | 0.9 |
| EBITDA 1 | - | - | -5.309 | -7.7 | - | - |
| EBIT 1 | -5.45 | - | -5.843 | -6.638 | - | - |
| Operating Margin | -4,467.21% | - | - | - | - | - |
| Earnings before Tax (EBT) 1 | -7.223 | -7.817 | -8 | -14.3 | - | - |
| Net income 1 | -7.223 | -7.817 | -8.023 | -14.3 | -4.8 | -5.8 |
| Net margin | -5,920.49% | - | - | - | - | -644.44% |
| EPS 2 | - | - | -0.2500 | -0.1900 | - | - |
| Free Cash Flow 1 | -5.76 | - | - | -7.1 | -6.6 | -8.4 |
| FCF margin | -4,721.68% | - | - | - | - | -933.33% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 3/22/19 | 3/31/22 | 3/30/23 | 3/28/24 | - | - |
1EUR in Million2EUR
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | 9.7 | - | - |
| Net Cash position 1 | - | - | 3.17 | - | - | - |
| Leverage (Debt/EBITDA) | - | - | - | -1.26 x | - | - |
| Free Cash Flow 1 | -5.76 | - | - | -7.1 | -6.6 | -8.4 |
| ROE (net income / shareholders' equity) | - | - | - | - | - | - |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - |
| Book Value Per Share | - | - | - | - | - | - |
| Cash Flow per Share 2 | -0.8900 | - | - | -0.1000 | -0.1000 | -0.1000 |
| Capex 1 | 0.43 | - | 0.21 | 2.9 | 0.4 | 0.5 |
| Capex / Sales | 352.47% | - | - | - | - | 55.56% |
| Announcement Date | 3/22/19 | 3/31/22 | 3/30/23 | 3/28/24 | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Sell
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
0.51
EUR
Average target price
0.46
EUR
Spread / Average Target
-9.80%
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +32.81% | 27.26M | |
| +3.34% | 3.67B | |
| -20.60% | 2.14B | |
| -6.63% | 1.99B | |
| +5.93% | 1.94B | |
| +0.77% | 1.72B | |
| -0.19% | 1.31B | |
| +5.69% | 1.21B | |
| -18.21% | 1.08B | |
| -2.47% | 1.01B |
- Stock Market
- Equities
- ALMIB Stock
- Financials Amoéba
